Real-time enrollment status for this systemic sclerosis clinical trial
Current Status
Recruiting
Checked: August 1, 2026 at 6:27 PM UTC
| NCT Number | NCT07497087 |
| Recruiting Status | Recruiting |
| Condition | Systemic Sclerosis |
| Phase | PHASE3 |
| Target Enrollment | 448 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | July 31, 2026 (Yesterday) |
As of August 1, 2026: Clinical trial NCT07497087 is currently recruiting participants. This phase3 study for systemic sclerosis is actively seeking new participants at 30 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07497087 is actively recruiting participants as of August 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07497087 was last updated Yesterday (July 31, 2026). HelloStudys verifies this status automatically.